| 2010 Corporate-Supported Symposia |
|
Educational support and symposia opportunities are available.
For more information, please contact Dina Kouveliotes at 877.571.4700 or dk@cardiometabolichealth.org |
Wednesday, October 20, 2010
6:00pm – 8:00pm
|
DINNER SYMPOSIUM
Cardiometabolic Risk Reduction in Patients with T2DM:
Expert Recommendations for Anti-hyperglycemic Therapy Selection to Achieve Optimal Outcomes
John Buse, MD; Anne Peters, MD; Robert Ratner, MD; Carol Wysham, MD
Supported by an educational grant from Amylin/Lilly
|
Thursday, October 21, 2010
6:30am – 8:00am
|
BREAKFAST SYMPOSIUM A
Overcoming Today’s Top Challenges in Ischemic Heart Disease: Clinical Controversies and Evidence-Based Solutions for Optimizing Patient Care
C. Noel Bairey Merz, MD; Christopher Cannon, MD; Peter Stone, MD;
Robert Wilensky, MD
Supported by an independent educational grant from Gilead Sciences
Medical Affairs |
6:30am – 8:00am
|
BREAKFAST ACTIVITY B
6:30am - 7:00am
Complimentary Breakfast Provided by the CMHC
7:00am - 8:00am
Evidence and Consensus on T2DM Patient Management: Early and Individualized Treatment to Goal (No CME credits will be offered)
James Gavin III, MD, PhD
Sponsored by sanofi-aventis |
12:00pm – 1:45pm
|
LUNCH SYMPOSIUM A
Optimizing the Role of GLP-1 Receptor Agonists in the T2DM Continuum of Care: Expert Recommendations and Interactive Clinical Scenarios
Lawrence Blonde, MD; Alan Garber, MD, PhD; Jack Leahy, MD;
Julio Rosenstock, MD
Supported by an educational grant from Novo Nordisk, Inc. |
12:00pm – 1:45pm
|
LUNCH SYMPOSIUM B
Individualizing and Optimizing Antiplatelet Therapy in High-Risk Patient Groups:
Moving Beyond a “One-Size-Fits-All” Approach
Eugene Braunwald, MD; Christopher Cannon, MD; Matthew Price, MD;
Steven Wiviott, MD
Supported by an educational grant from Daiichi Sankyo, Inc.
and Eli Lilly and Company |
6:30pm – 8:30pm
|
DINNER SYMPOSIUM
Can We Control Diabetes and Cardiometabolic Risk Through Weight Loss? Examining the Clinical Implications of Obesity Therapies in Late-Stage Development
Robert Eckel, MD; Kishore Gadde, MD; W. Timothy Garvey, MD; Michelle Look, MD
Supported by an educational grant from Vivus, Inc. |
Friday, October 22, 2010
6:30am – 8:00am
|
BREAKFAST SYMPOSIUM
Implementing High-Dose Insulin Therapy for Patients with T2DM
and Severe Insulin Resistance in Clinical Practice:
Expert Recommendations and Practical Considerations
Wendy Lane, MD; Anne Peters, MD; Jay Skyler, MD
Supported by an educational grant from Lilly, USA, LLC |
12:15pm – 2:00pm
|
LUNCH SYMPOSIUM A
Advances in Statin Therapy: Expert Recommendations for Optimizing the Management of Dyslipidemia in the Clinically Complex Patient
Christie Ballantyne, MD; Eliot Brinton, MD; Tara Dall, MD
Supported by an educational grant from Kowa Pharmaceuticals America, Inc.
and Lilly USA, LLC |
12:15pm - 2:00pm
|
LUNCH SYMPOSIUM B
Improving Endothelial Function with New-Generation Beta Blockers:
Optimal Strategies for Controlling Hypertension and Reducing CV Risk
George Bakris, MD; Thomas Giles, MD; R. Preston Mason, PhD
Supported by an educational grant from Forest Laboratories, Inc. |
6:00pm – 8:00pm
|
DINNER SYMPOSIUM
Diabetes, Dyslipidemia, and Hypertension:
Identifying the Connections
and Seizing the Opportunities for Global Cardiometabolic Risk Reduction
George Bakris, MD; Om Ganda, MD; Ronald Goldberg, MD; Suzanne Oparil, MD
Supported by an educational grant from Daiichi Sankyo, Inc. |
Saturday, October 23, 2010
6:30am – 8:00am
|
BREAKFAST SYMPOSIUM
The Evolving Role of Endothelin Receptor Antagonists in PAH Management: Opportunities for Optimizing Patient Care and Outcomes
David Badesch, MD; Paul Forfia, MD; Myung Park, MD
Supported by an educational grant from Actelion Pharmaceuticals US, Inc. |
|
Join Our Mailing List
2010 Congress Details
2009 Congress Details 
2009 Online CME Activity
Useful Links
Recommend This Site 
